Secondary constipation due to drug intake and endocrine, neurological, and psychiatric diseases-conservative therapeutic options;Sekundäre Form der Obstipation aufgrund von medikamentsen Nebenwirkungen und endokrinen, neurologischen und psychiatrischen Erkrankungen-medikaments-konservative Therapieoptionen

Viszeralmedizin: Gastrointestinal Medicine and Surgery

Volumn 28, Issue 4, 2012, Pages 250-254

  Pehl, Christian ^a  

^a Medizinische Klinik   (Germany)

Author keywords

Conservative therapy; Diabetes mellitus; Parkinson's disease; Secondary constipation; Side effect

Indexed keywords

ARTICLE; CONSTIPATION; DEPRESSION; DIABETES MELLITUS; DISEASE ASSOCIATION; ENDOCRINE DISEASE; HUMAN; HYPOTHYROIDISM; MENTAL DISEASE; NEUROLOGIC DISEASE; PARKINSON DISEASE; SECONDARY CONSTIPATION;

EID: 84866172611     PISSN: 16626664     EISSN: 16626672     Source Type: Journal    
DOI: 10.1159/000341720     Document Type: Article

References (42)

1. Wirz S, Klaschik E: Management of constipation in palliative care patients undergoing opioid therapy: is polyethylene glycol an option? Am J Hosp Palliat Care 2005;22:375-381. (Pubitemid 41432865)
2. Kienzle-Horn S, Vix J, Schuijt C, Peil H, Jordan C, Kamm M: Comparison of bisacodyl and sodium picosulphate in the treatment of chronic constipation. Curr Med Res Opin 2007;23:691-699. (Pubitemid 46631472)
3. Sloots C, Rykx A, Cools M, Kerstens R, De Pauw M: Efficacy and safety of prucalopride in patients with chronic noncancer pain suffering from opioidinduced constipation. Dig Dis Sci 2010;55: 2912-2921.
4. Greenwood-Van Meerveld B, Standifer K: Methylnaltrexone in the treatment of opioid-induced constipation. Clin Exp Gastroenterol 2008;1:49-58.
5. Rossol S: Obstipation bei Patienten mit Diabetes mellitus. MMW Fortschr Med 2007;149:39-42. (Pubitemid 350143938)
6. Shakil A, Church R, Rao S: Gastrointestinal complications of diabetes. Am Fam Physician 2008;77: 1697-1704.
7. Jung H, Kim D, Moon I, Hong Y: Colonic transit time in diabetic patients-comparison with healthy subjects and the effect of autonomic neuropathy. Yonsei Med J 2003;44:265-272. (Pubitemid 36592188)
8. Hackelsberger N, Schmidt T, Renner R, Widmer R, Pfeiffer A, Kaess H: Ambulatory long-term jejunal manometry in diabetic patients with cardiac autonomic neuropathy. Neurogastroenterol Motil 1997;9:77-83. (Pubitemid 27260804)
9. Ramkumar D, Rao S: Efficacy and safety of traditional medical therapies for chronic constipation: systematic review. Am J Gastroenterol 2005;100: 936-971. (Pubitemid 40592390)
10. Ron Y, Wainstein J, Leibovitz A, Monastirsky N, Habot B, Avni Y, Segal R: The effect of acarbose on the colonic transit time of elderly long-term care patients with type 2 diabetes mellitus. J Gerontol A Biol Sci Med Sci 2002;57:M111-114. (Pubitemid 34177409)
11. Abboud B, Daher R, Boujaoude J: Digestive manifestations of parathyroid disorders. World J Gastroenterol 2011;17:4063-4066.
12. Cohen M, Phay J, Albinson C, DeBenedetti M, Skinner M, Lairmore T, Doherty G, Balfe D, Wells S, Moley J: Gastrointestinal manifestations of multiple endocrine neoplasia type 2. Ann Surg 2002; 235:648-655. (Pubitemid 34454152)
13. Ebert E: The thyroid and the gut. J Clin Gastroenterol 2010;44:402-406.
14. Mler-Lissner S, Kamm M, Scarpignato C, Wald A: Myths and misconceptions about chronic constipation. Am J Gastroenterol 2005;100:232-242. (Pubitemid 41623292)
15. Deen K, Seneviratne S, de Silva H: Anorectal physiology and transit in patients with disorders of thyroid metabolism. J Gastroenterol Hepatol 1999; 14:384-387. (Pubitemid 30055471)
16. Winge K, Rasmussen D, Werdelin L: Constipation in neurological diseases. J Neurol Neurosurg Psychiatry 2003;74:13-19. (Pubitemid 36069029)
17. Awad R: Neurogenic bowel dysfunction in patients with spinal cord injury, myelomeningocele, multiple sclerosis and Parkinson's disease. World J Gastroenterol 2011;17:5035-5048.
18. Ebert E: Gastrointestinal involvement in spinal cord injury: a clinical perspective. J Gastrointestin Liver Dis 2012;21:75-82.
19. Aya SS, Leblebici B, Say S, Bayramoglu M, Niron E: The effect of abdominal massage on bowel function in patients with spinal cord injury. Am J Phys Med Rehabil 2006;85:951-955. (Pubitemid 44789610)
20. Krassioukov A, Eng J, Claxton G, Sakakibara B, Shum S: Neurogenic bowel management after spinal cord injury: a systematic review of the evidence. Spinal Cord 2010;48:718-733.
21. Krogh K, Jensen M, Gandrup P, Laurberg S, Nilsson J, Kerstens R, De Pauw M: Efficacy and tolerability of prucalopride in patients with constipation due to spinal cord injury. Scand J Gastroenterol 2002;37:431-436. (Pubitemid 34274327)
22. Rosman A, Chaparala G, Monga A, Spungen A, Bauman W, Korsten M: Intramuscular neostigmine and glycopyrrolate safely accelerated bowel evacuation in patients with spinal cord injury and defecatory disorders. Dig Dis Sci 2008;53:2710-2713.
23. Emmanuel A: Review of the efficacy and safety of transanal irrigation for neurogenic bowel dysfunction. Spinal Cord 2010;48:664-673.
24. Tsai P, Wang C, Chiu F, Tsai Y, Chang Y, Chuang T: Efficacy of functional magnetic stimulation in neurogenic bowel dysfunction after spinal cord injury. Rehabil Med 2009;41:41-47.
25. Jost W, Eckardt V: Constipation in idiopathic Parkinson's disease. Scand J Gastroenterol 2003; 38:681-686. (Pubitemid 36920487)
26. Derkinderen P, Rouaud T, Lebouvier T, Bruley des Varannes S, Neunlist M, De Giorgio R: Parkinson disease: the enteric nervous system spills its guts. Neurology 2011;77:1761-1777.
27. Ashraf W, Pfeiffer R, Park F, Lof J, Quigley E: Constipation in Parkinson's disease: objective assessment and response to psyllium. Mov Disord 1997;12:946-951. (Pubitemid 27496772)
28. Zangaglia R, Martignoni E, Glorioso M, Ossola M, Riboldazzi G, Calandrella D, Brunetti G, Pacchetti C: Macrogol for the treatment of constipation in Parkinson's disease. A randomized placebo-controlled study. Mov Disord 2007;22:1239-1244. (Pubitemid 47325029)
29. Jost W, Schimrigk K: Long-term results with cisapride in Parkinson's disease. Mov Disord 1997;12: 423-425. (Pubitemid 27216144)
30. Cassani E, Privitera G, Pezzoli G, Pusani C, Madio C, Iorio L, Barichella M: Use of probiotics for the treatment of constipation in Parkinson's disease patients. Minerva Gastroenterol Dietol 2011;57: 117-121.
31. Preziosi G, Raptis D, Storrie J, Raeburn A, Fowler C, Emmanuel A: Bowel biofeedback treatment in patients with multiple sclerosis and bowel symptoms. Dis Colon Rectum 2011;54:1114-1121.
32. Afridi M, Siddiqui M, Ansari A: Gastrointestinal somatization in males and females with depressive disorder. J Pak Med Assoc 2009;59:675-679.
33. HillilM, Hnen J, Heikkinen M, Fkkilä M: Gastrointestinal complaints among subjects with depressive symptoms in the general population. Aliment Pharmacol Ther 2008;28:648-654.
34. Rao S, Mudipalli R, Stessman M, Zimmerman B: Investigation of the utility of colorectal function tests and Rome II criteria in dyssynergic defecation (Anismus). Neurogastroenterol Motil 2004;16: 589-596. (Pubitemid 39472192)
35. Koh C, Young C, Young J, Solomon MJ: Systematic review of randomized controlled trials of the effectiveness of biofeedback for pelvic floor dysfunction. Br J Surg 2008;95:1079-1087.
36. Matsunami K, Takagi H, Ichigo S, Murase T, Ikeda T, Imai A: Peptide YY producing strumal carcinoid tumor of the ovary. Eur J Gynaecol Oncol 2011;32: 201-202.
37. Ebert E, Nagar M; Weston S, Thumshirn M, Wiste J, Camilleri M: Gastrointestinal manifestations of amyloidosis. Am J Gastroenterol 2008;103:776-787. (Pubitemid 351405997)
38. Gottrand F, Guillonneau I, Carpentier A: Clinical and upper gastrointestinal motility features in systemic sclerosis and related disorders. Am J Gastroenterol 1998;93:1085-1089.
39. Tieleman A, van Vliet J, Jansen J, van der Kooi A, Borm G, van Engelen B: Gastrointestinal involvement is frequent in Myotonic Dystrophy type 2. Neuromuscul Disord 2008;18:646-649.
40. Basilisco G, Barbera R, Vanoli M, Bianchi P: Anorectal dysfunction and delayed colonic transit in patients with progressive systemic sclerosis. Dig Dis Sci 1993;38:1525-1529. (Pubitemid 23266637)
41. Ito T, Sakakibara R, Ito S, Uchiyama T, Liu Z, Yamamoto T, Yamaguchi T, Odaka T, Higashi M, Hattori T: Mechanism of constipation in familial amyloid polyneuropathy: a case report. Intern Med 2006;45:1173-1175. (Pubitemid 44773971)
42. Boeckxstaens G, Bartelsman J, Lauwers L, Tytgat G: Treatment of GI dysmotility in scleroderma with the new enterokinetic agent prucalopride. Am J Gastroenterol 2002;97:194-197. (Pubitemid 34059787)